Shao-Lee Lin Discloses Investment at Cue Biopharma with 6.2% StakeTradingView·Aug 21 at 09:06 PMCUE+11.44%
Cue Biopharma GAAP EPS of -$24.14 misses by $22.23, revenue of $7.88M beats by $5.78Mbusinessinsider·Aug 17 at 07:51 AMCUE+11.44%
Cue Biopharma Chief Executive Officer Sold Shares Worth Over $1.6MTradingView·Aug 15 at 12:50 AMCUE+11.44%
Cue Biopharma (NASDAQ:CUE) Posts Quarterly Earnings Results, Misses Estimates By $22.45 EPSMarket Beat·Aug 15 at 12:26 AMCUE+11.44%
12 Health Care Stocks Moving In Friday's After-Market Sessionbenzinga_article·Aug 14 at 09:06 PMOBX-2.68%QTRX-5.99%
Cue Biopharma Reports Second Quarter 2026 Financial Results and Recent Business HighlightsUnusual Whales·Aug 14 at 08:06 PMCUE+11.44%
Cue Biopharma Q2 FY26 net loss widens to $153.07 million; revenue rises 162.61% to $7.88 millionPUBT·Aug 14 at 08:03 PMCUE+11.44%
Cue Biopharma (NASDAQ:CUE) Trading Down 3.8% - Should You Sell?Market Beat·Aug 11 at 04:20 AMCUE+11.44%
Cue Biopharma CFO James M. Ahlers files initial beneficial ownership statementPUBT·Aug 3 at 08:18 PMCUE+11.44%
Cue Biopharma files Form 3 for Chief Medical Officer, Head of R&D Dominique BoriePUBT·Jul 15 at 10:58 PMCUE+11.44%
U.S. stock market update: Cue Biopharma down 14.87%, executive appointments and financing raise concernsPrice Alert·Jul 13 at 05:22 PMCUE+11.44%
